- Home
- ECOR vs GRF Comparison
ECOR vs GRF Comparison
Compare ECOR & GRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- GRF
- Stock Information
- Founded
- ECOR 2005
- GRF 1989
- Country
- ECOR United States
- GRF United States
- Employees
- ECOR N/A
- GRF N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- GRF Finance/Investors Services
- Sector
- ECOR Health Care
- GRF Finance
- Exchange
- ECOR Nasdaq
- GRF Nasdaq
- Market Cap
- ECOR 39.7M
- GRF 39.3M
- IPO Year
- ECOR 2018
- GRF N/A
- Fundamental
- Price
- ECOR $5.37
- GRF $10.08
- Analyst Decision
- ECOR Strong Buy
- GRF
- Analyst Count
- ECOR 2
- GRF 0
- Target Price
- ECOR $25.50
- GRF N/A
- AVG Volume (30 Days)
- ECOR 118.5K
- GRF 3.0K
- Earning Date
- ECOR 08-06-2025
- GRF 01-01-0001
- Dividend Yield
- ECOR N/A
- GRF 3.70%
- EPS Growth
- ECOR N/A
- GRF N/A
- EPS
- ECOR N/A
- GRF 1.16
- Revenue
- ECOR $27,700,000.00
- GRF N/A
- Revenue This Year
- ECOR $23.21
- GRF N/A
- Revenue Next Year
- ECOR $44.10
- GRF N/A
- P/E Ratio
- ECOR N/A
- GRF $8.15
- Revenue Growth
- ECOR 30.16
- GRF N/A
- 52 Week Low
- ECOR $4.16
- GRF $7.93
- 52 Week High
- ECOR $19.49
- GRF $10.19
- Technical
- Relative Strength Index (RSI)
- ECOR 42.75
- GRF 49.92
- Support Level
- ECOR $4.16
- GRF $10.02
- Resistance Level
- ECOR $5.74
- GRF $10.15
- Average True Range (ATR)
- ECOR 0.53
- GRF 0.06
- MACD
- ECOR -0.16
- GRF -0.02
- Stochastic Oscillator
- ECOR 37.19
- GRF 25.53
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About GRF Eagle Capital Growth Fund Inc.
Eagle Capital Growth Fund Inc is a diversified closed-end investment company. The fund's objective is long-term growth utilizing the concept of total return for selecting investments. It seeks to achieve its investment objectives by investing predominantly in U.S. issuer common stock by giving preference to high-quality companies, where high quality denotes substantial operating income margins, high returns on capital, and robust balance sheets.